Apollo Endosurgery Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
APEN Nasdaq 3841 http://apolloendo.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apollo Endosurgery Inc

What Does Apollo Endosurgery Inc’s (NASDAQ:APEN) Ownership Structure Look Like? - Sep 18th, 2018 9:05 am
Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biotherapeutics, Forward Industries, Apollo Endosurgery, and Myomo — Research Highlights Growth, Revenue, and Consolidated Results - Aug 16th, 2018 5:40 am
Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results - Aug 8th, 2018 2:01 pm
Apollo Endosurgery, Inc. to Report Second Quarter Results on August 8, 2018 - Aug 6th, 2018 2:01 pm
Apollo Endosurgery Receives Special 510(k) Clearance for OverStitch™ Sx Endoscopic Suturing System - Jun 28th, 2018 2:01 pm
Apollo Endosurgery, Inc. Announces Closing of Public Offering of Common Stock and Underwriter’s Full Exercise of Over-Allotment Option - Jun 22nd, 2018 2:01 pm
Benzinga's Daily Biotech Pulse: Sarepta's DMD Gene Therapy, Anika's Flunked Trial, Eidos To Commence Trading - Jun 20th, 2018 6:36 am
Apollo Endosurgery, Inc. Announces Pricing of $20.6 Million Public Offering of Common Stock - Jun 20th, 2018 5:00 am
Apollo Endosurgery, Inc. Announces Commencement of Public Offering of Common Stock - Jun 19th, 2018 2:00 pm
Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW) - Jun 5th, 2018 7:00 am
Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery - Jun 4th, 2018 2:01 pm
Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA® Intragastric Balloon System - Jun 4th, 2018 11:00 am
Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week® 2018 titled: “Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon” - Jun 4th, 2018 6:00 am
Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors - May 31st, 2018 3:59 pm
Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference - May 24th, 2018 3:44 pm
Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients - May 14th, 2018 3:00 am
Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures - May 8th, 2018 2:01 pm
Free Post Earnings Research Report: Edwards Lifesciences’ Adjusted Sales Grew 9.3%; Adjusted EPS Surged 30% - May 8th, 2018 5:40 am
Apollo Endosurgery, Inc. Reports First Quarter 2018 Results - May 3rd, 2018 2:01 pm